Inventor · disambiguated record
Karl Ploessl
Also filed as: PLOESSL KARL
4 granted patents·3 pending applications·17 citations·filing 2010–2021
72Inventor score
Top patents by PatentIndex Score
7 records- 0188US10912849B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2018·Granted Feb 9, 2021·6 cites·16 claims
- 0288US10688200B2Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapyFIVE ELEVEN PHARMA INC·Filed 2016·Granted Jun 23, 2020·8 cites·22 claims
- 0381US11071794B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2020·Granted Jul 27, 2021·2 cites·13 claims
- 0471US8747809B2Single diastereomers of 4-fluoroglutamine and methods of their preparation and useKUNG HANK F·Filed 2010·Granted Jun 10, 2014·1 cites·25 claims
- 0549US2024158420A1[18f]a1f labeled psma targeting molecular probe and preparation method thereforFIVE ELEVEN PHARMA INC·Filed 2021·Application pending·0 cites
- 0649US2024139350A1Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method thereforFIVE ELEVEN PHARMA INC·Filed 2021·Application pending·0 cites
- 0746US2022125959A1Prostate-specific membrane antigen (psma) inhibitors as diagnostic and radionuclide therapeutic agentsFIVE ELEVEN PHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karl Ploessl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →